PLSE
Pulse Biosciences Inc
51.60$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -50.0% | -100.0% | – | +207.0% | +51.9% | +8.2% | – | |
| – | +14.3% | -1.6% | -11.0% | +0.4% | +211.6% | -66.0% | -5.7% | +4.5% | +86.0% | -28.7% | -26.2% | – | |
| – | – | -120.8% | – | – | – | -134.0% | – | – | – | – | +419.4% | – | |
| – | +4.4% | -13.6% | +7.3% | +6.5% | +38.4% | -3.3% | +17.2% | -5.7% | -4.1% | +15.2% | +34.8% | – | |
| – | +25.2% | -18.2% | +16.1% | +32.4% | +61.3% | -19.5% | +5.9% | +7.3% | +81.3% | -58.6% | +28.3% | – | |
| – | +11.4% | -17.7% | +13.7% | +16.5% | +48.4% | -10.9% | +10.9% | +0.8% | -10.8% | +6.6% | +32.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.1% | -22.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +107.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.